OUR ADVISORY BOARD
Professor Farzin Farzaneh
DPhil, FRCPath, FRSB
Scientific Advisor & Research Partner
Expert in Molecular Medicine and Cell Therapies at King’s College London, whose Cell therapy Unit offers one of the most advanced GMP Cell Production facilities in Europe. Experienced in running GMP facilities for the production of cell and gene therapy based investigational medicinal products since 2001
Dr Jonathan Milner
Funding & Growth Advisor
Jonathan Milner, co-founder and currently Deputy Chairman of Abcam plc, is an experienced entrepreneur and investor and is passionate about supporting UK healthcare and high-tech start-ups. He has provided considerable investment to LIfT BioSciences, and intends to help LIfT BioSciences get N-LIfT to market and to secure a successful exit. Jonathan already helped three tech companies IPO on AIM.
Dr Tony de Fougerolles
Scientific & Partnerships Advisor
Successful Biotech entrepreneur with a strong background in successfully developing and advancing multiple different transformative therapeutic drug platforms in both the nucleic acid and biologics space. In addition, his in-depth expertise in drug development has led to the progression of multiple assets through clinical trials. Prior to joining Evox Therapeutics, Tony was CSO at Ablynx NV and Moderna Therapeutics, and VP Research at Alnylam Pharmaceuticals. PhD in Immunology from Harvard University.
Prof James Spicer
MRCP, PhD, FCRP
Principle Investigator & Clinical Advisor
Professor of Experimental Cancer Medicine, King’s College London, and Consultant in Medical Oncology, Guy’s and St. Thomas’ Hospitals London. He holds a PhD in Cancer Biology from the Institute of Cancer Research in London, and a degree in biochemistry from the University of Oxford. Our Principle Investigator for our planned PoC trial.
Patient Interests Advisor
Founder & CEO of Pancreatic Cancer Action, Founding Board Member and Awareness Group Lead for Pancreatic Cancer Europe. Ali is herself a rare survivor of Pancreatic Cancer.